Check-Cap Ltd.

Check-Cap Ltd.

$1.33
-0.92 (-40.84%)
NASDAQ Capital Market
USD, IL
Medical - Diagnostics & Research

CHEK Price Chart

Basic
Market Cap$3.64M
Price$1.33
52 Week Range0.61-3.45
Beta0.18
Margins
Gross Profit Margin0.00%
Operating Profit Margin0.00%
Net Profit Margin0.00%
Valuation (TTM)
P/E Ratio-0.59
Price to Sales Ratio0.00
Price to Book Ratio0.33
PEG Ratio-0.22

Industry

Medical - Diagnostics & Research

Sector

Healthcare

Full-Time Employees

85

IPO Date

2015-03-04T00:00:00.000Z

Description

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.

Phone

972 4 830 3401

Address

Check-Cap Building, Isfiya, 30090, IL

CIK

0001610590